HomeCompareUSMAX vs MRK

USMAX vs MRK: Dividend Comparison 2026

USMAX yields 17.26% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 USMAX wins by $19968328.49M in total portfolio value
10 years
USMAX
USMAX
● Live price
17.26%
Share price
$11.59
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19968328.55M
Annual income
$19,748,479,334,663.05
Full USMAX calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — USMAX vs MRK

📍 USMAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSMAXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USMAX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USMAX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USMAX
Annual income on $10K today (after 15% tax)
$1,466.78/yr
After 10yr DRIP, annual income (after tax)
$16,786,207,434,463.59/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, USMAX beats the other by $16,786,207,425,866.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USMAX + MRK for your $10,000?

USMAX: 50%MRK: 50%
100% MRK50/50100% USMAX
Portfolio after 10yr
$9984164.30M
Annual income
$9,874,239,672,388.42/yr
Blended yield
98.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

USMAX
No analyst data
Altman Z
0.7
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USMAX buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSMAXMRK
Forward yield17.26%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$19968328.55M$57.7K
Annual income after 10y$19,748,479,334,663.05$10,113.78
Total dividends collected$19953661.60M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: USMAX vs MRK ($10,000, DRIP)

YearUSMAX PortfolioUSMAX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,151$3,451.25$11,213$373.04+$2.9KUSMAX
2$24,271$9,128.88$12,667$512.06+$11.6KUSMAX
3$55,235$29,265.21$14,439$708.14+$40.8KUSMAX
4$183,590$124,488.33$16,640$988.16+$166.9KUSMAX
5$969,851$773,409.74$19,432$1,394.07+$950.4KUSMAX
6$8,674,560$7,636,819.35$23,057$1,992.90+$8.65MUSMAX
7$136,955,435$127,673,656.70$27,889$2,894.79+$136.93MUSMAX
8$3,914,268,682$3,767,726,365.98$34,518$4,286.29+$3914.23MUSMAX
9$205,466,556,604$201,278,289,114.81$43,912$6,494.35+$205466.51MUSMAX
10$19,968,328,550,230$19,748,479,334,663.05$57,714$10,113.78+$19968328.49MUSMAX

USMAX vs MRK: Complete Analysis 2026

USMAXStock

The investment seeks long-term capital appreciation, with emphasis on the protection of capital during unfavorable market conditions. The fund will invest at least 80% of its net assets (plus any borrowings made for investment purposes) in investments that are tied economically to the U.S. It pursues its investment goal primarily through investments in equity securities that broadly represent the U.S. equities market; derivative instruments related to the U.S. equities market; and fixed income securities (including money market and other short-term or variable-rate, high quality securities and related ETFs).

Full USMAX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this USMAX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USMAX vs SCHDUSMAX vs JEPIUSMAX vs OUSMAX vs KOUSMAX vs MAINUSMAX vs JNJUSMAX vs ABBVUSMAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.